The MyBrain study investigates the brain function of children, adolescents and young adults during and after chemo treatment for cancer. The tests include 1) cognitive skills such as memory and attention; 2) the brain's electrical activity; 3) and biological markers related to brain function. The aim of the study is to better understand the trajectories of cognitive functioning and measures that have been associated with cognitive impairment in patients treated with chemotherapy.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Performance on clinical neurocognitive tests: Wechlers scale
Timeframe: T0: within 30 days of diagnosis
Performance on clinical neurocognitive tests: Wechlers scale
Timeframe: T2: end of treatment (2 weeks after the final antineoplastic treatment)
Performance on clinical neurocognitive tests: Wechlers scale
Timeframe: T3: 6 months after end of treatment